Lv21
138 积分 2024-04-07 加入
Comparison of RECIST, iRECIST, and PERCIST for the Evaluation of Response to PD-1/PD-L1 Blockade Therapy in Patients With Non–Small Cell Lung Cancer
8天前
已完结
First-in-Humans PET Imaging ofKRASG12CMutation Status in Non–Small Cell Lung and Colorectal Cancer Patients Using [18F]PFPMD
20天前
已完结
Head-to-head comparison of 68Ga-FT-FAPI with 68Ga-FAPI-04 in patients with gastrointestinal tumors
20天前
已完结
Daraxonrasib in Previously Treated Advanced RAS -Mutated Pancreatic Cancer
1个月前
已完结
Gemcitabine/Nab-Paclitaxel versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: A European Multicenter Study
2个月前
已完结
Gemcitabine Plus Nab-Paclitaxel Versus FOLFIRINOX in Locally Advanced, Unresectable Pancreatic Cancer
2个月前
已完结
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib
2个月前
已完结
Pancreatic cancer
3个月前
已完结
Exploring chemotherapy holiday and drugs re-challenge in advanced pancreatic cancer patients
3个月前
已完结
Randomized Phase II Trial Evaluating Two Sequential Treatments in First Line of Metastatic Pancreatic Cancer: Results of the PANOPTIMOX-PRODIGE 35 Trial
5个月前
已关闭
皖公网安备34019202002308
